BioSpace News Archive

Achieve Life Sciences, Inc. today announced that it will report its third quarter 2018 financial results on Wednesday, November 7, 2018.

Industry Experts Offer Insight for Individuals Diagnosed with Late-Stage Illness

United Therapeutics Corporation today announced its financial results for the quarter ended September 30, 2018.

Ophthotech Enters into Second Series of Gene Therapy Agreements with the University of Pennsylvania and the University of Florida for Exclusive Option for Novel Product Candidates to Treat Best Disease

Renovia Inc. today announced Tara Butler, M.D. has joined its Board of Directors.

--Amended Agreement Now Covers the Current EU Member States (including the UK) plus Eight Other Countries--

Conference call scheduled today at 9:00 a.m. ET

a new analysis of genetic data from a large prospective registry and clinical data from several randomized trials indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy.

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced the identification of novel targets on misfolded, pathological forms of tau.

This flu season’s vaccine market will be influenced by the return of nasal spray vaccines, according to Kalorama Information.